Abstract
Gut microbiota have gained increasing recognition for their vital role in human health, particularly in their interactions with the immune system, including their involvement in obesity prevention through the production of IgA antibodies. These microbiotas are instrumental in lipid breakdown, utilizing lipases to break down phospholipids and triglycerides into polar head groups and free lipids. The loss of these beneficial microbes has been suggested as a potential cause for disruptions in various homeostatic mechanisms within our bodies. Factors contributing to this loss may encompass antibiotic usage, heightened sanitation practices, and low-fiber diets. Obesity, more prevalent in developed nations, is linked to the diminished regulatory immune responses associated with specific beneficial microbial species. This review article aims to provide a comprehensive exploration of how gut microbiota influence lipid metabolism, considering T-cell-mediated regulation, and examines the effects of antibiotics on the gut microbial population.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Research and Scientific Innovation
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
